Literature DB >> 28298316

Paediatric infectious keratitis: a case series of 107 children presenting to a tertiary referral centre.

Julia Dutra Rossetto1,2, Kara M Cavuoto1, Carla J Osigian1, Ta Chen Peter Chang1, Darlene Miller1, Hilda Capo1, Oriel Spierer1,3.   

Abstract

BACKGROUND/AIMS: Corneal ulcers can result in severe visual impairment in children. The recent trends of paediatric microbial ulcerative keratitis in the USA are unknown. The purpose of this study is to report the risk factors, microbiological profile and treatment outcomes of paediatric microbial keratitis in South Florida.
METHODS: A university-based tertiary eye care centre retrospective case series between 1992 and 2015. Medical records of 107 paediatric patients (age <18 years) with the diagnosis of microbial ulcerative keratitis were analysed. Patient demographics, culture data, microbial susceptibility, management trends and patient outcomes were collected.
RESULTS: Mean age of patients was 13±4.6 years (range 0.2-17 years). The most common associated risk factor was contact lens wear (77.6%), followed by ocular trauma (8.4%). Systemic factors were present in 4.7% of cases. Cultures were taken from 89 patients. A total of 74 organisms were isolated from the 52 corneal scrapings with growth, yielding a 58.4% positivity rate. Seventeen microbial species were identified, with a predominance of Pseudomonas aeruginosa (46.2%), followed by Stenotrophomonas maltophilia (19.2%) and Fusarium (13.5%). Combined fortified antibiotics were the most common treatment (51.4%). Mean follow-up time was 40.6±91.6 weeks (range: 0.3-480 weeks). The mean visual acuity improved from 20/160 to 20/50 (p<0.0001). No therapeutic penetrating keratoplasty was needed.
CONCLUSIONS: In this study, contact lens wear was the most frequent risk factor in infectious keratitis in children. P. aeruginosa was the most common microorganism present in our setting. The majority of the cases responded well to medical management. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Child health (paediatrics); Contact lens; Cornea; Infection; Microbiology

Mesh:

Substances:

Year:  2017        PMID: 28298316     DOI: 10.1136/bjophthalmol-2016-310119

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

Review 1.  The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance.

Authors:  Lawson Ung; Paulo J M Bispo; Swapna S Shanbhag; Michael S Gilmore; James Chodosh
Journal:  Surv Ophthalmol       Date:  2018-12-24       Impact factor: 6.048

2.  Commentary: Pediatric infectious keratitis.

Authors:  Manpreet Kaur; Jeewan S Titiyal
Journal:  Indian J Ophthalmol       Date:  2020-03       Impact factor: 1.848

3.  Demographic details, risk factors, microbiological profile, and clinical outcomes of pediatric infectious keratitis cases in North India.

Authors:  Manisha Singh; Abha Gour; Arpan Gandhi; Umang Mathur; Javed H Farooqui
Journal:  Indian J Ophthalmol       Date:  2020-03       Impact factor: 1.848

4.  Severe corneal abscess: epidemiology and clinicobacteriological aspect.

Authors:  Ahmed Mahjoub; Safa Hadj Salah; Nouha Gayed; Nadia Ben Abdessalem; Fethi Krifa; Leila Knani; Mahjoub Hachemi
Journal:  Tunis Med       Date:  2021 Juin

5.  Pathogens and Antibiotic Susceptibilities of Global Bacterial Keratitis: A Meta-Analysis.

Authors:  Zijun Zhang; Kai Cao; Jiamin Liu; Zhenyu Wei; Xizhan Xu; Qingfeng Liang
Journal:  Antibiotics (Basel)       Date:  2022-02-12

6.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

7.  Pediatric Non-Viral Microbial Keratitis: Predisposing Factors, Microbiological Profile, Treatment Modalities, and Visual Outcome.

Authors:  Nada N Alwohaibi; Malak Bamashmoos; Abdulaziz Al Somali
Journal:  Clin Ophthalmol       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.